News & Events
Hemanext® Inc. Receives CE Mark Certification for Innovative Red Blood Cell (RBC) Processing & Storage System
Company to launch red blood cell (RBC) processing and storage system in select European markets in 2021, with wider distribution in Europe and the Americas in 2022 and future years.
Sickle Cell Disease Association of America, Inc. Launches New Educational Materials to Support Children’s Blood Transfusion
Sickle Cell Disease Association of America, Inc. (SCDAA) and Hemanext Inc., today announced the launch of new educational material to help SCDAA deliver on its mission and meet its goals.
INVESTORS
Current and prospective investors access to the investor Portal
COVID 19 Updates
Follow the course of COVID-19 and locate where to donate blood
Educational Symposiums
View educational material and interesting presentations
Our Science
Stored Blood
The average human body stores about 5.6 liters of blood. As it circulates through the body several times each minute, it accomplishes a variety of functions.
Storage Lesion
Clinical Implications
Numerous studies pertaining to clinical implications of storage lesion suggest a linkage to hyper-coagulability, inflammation, impaired perfusion, immuno-modulation, organ dysfunction13, and mortality14.
Hypoxic Storage
Hemanext Research
Worldwide Patent Assets
Accepted Scientific Abstracts
Total Publications
Our Technology
Hemanext ONE®
The Hemanext ONE® system enables processing and storage of oxygen and carbon dioxide reduced red blood cells. Our system seeks to provide a more consistent and higher red blood cell (RBC) by removing the fuel for oxidative damage.